- Home
- ALOT vs COYA Comparison
ALOT vs COYA Comparison
Compare ALOT & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALOT
- COYA
- Stock Information
- Founded
- ALOT 1969
- COYA 2020
- Country
- ALOT United States
- COYA United States
- Employees
- ALOT N/A
- COYA N/A
- Industry
- ALOT Computer peripheral equipment
- COYA Biotechnology: Pharmaceutical Preparations
- Sector
- ALOT Technology
- COYA Health Care
- Exchange
- ALOT Nasdaq
- COYA Nasdaq
- Market Cap
- ALOT 105.3M
- COYA 104.3M
- IPO Year
- ALOT N/A
- COYA 2022
- Fundamental
- Price
- ALOT $15.00
- COYA $6.08
- Analyst Decision
- ALOT
- COYA Strong Buy
- Analyst Count
- ALOT 0
- COYA 3
- Target Price
- ALOT N/A
- COYA $16.67
- AVG Volume (30 Days)
- ALOT 9.1K
- COYA 142.0K
- Earning Date
- ALOT 12-12-2024
- COYA 11-06-2024
- Dividend Yield
- ALOT N/A
- COYA N/A
- EPS Growth
- ALOT 591.76
- COYA N/A
- EPS
- ALOT 0.83
- COYA N/A
- Revenue
- ALOT $150,643,000.00
- COYA $9,554,315.00
- Revenue This Year
- ALOT N/A
- COYA N/A
- Revenue Next Year
- ALOT N/A
- COYA $54.20
- P/E Ratio
- ALOT $17.56
- COYA N/A
- Revenue Growth
- ALOT 0.29
- COYA N/A
- 52 Week Low
- ALOT $11.83
- COYA $4.75
- 52 Week High
- ALOT $18.83
- COYA $10.69
- Technical
- Relative Strength Index (RSI)
- ALOT 65.37
- COYA 38.00
- Support Level
- ALOT $13.84
- COYA $5.90
- Resistance Level
- ALOT $14.25
- COYA $7.50
- Average True Range (ATR)
- ALOT 0.43
- COYA 0.50
- MACD
- ALOT 0.15
- COYA -0.17
- Stochastic Oscillator
- ALOT 100.00
- COYA 10.91
About ALOT AstroNova Inc.
AstroNova Inc designs, develops, manufactures, and distributes a broad range of specialty printers and data acquisition and analysis systems, including both hardware and software, which incorporate technologies to acquire, store, analyze, and present data in multiple formats sold under the QuickLabel, TrojanLabel and GetLabels brand names. Its target markets for hardware and software products include aerospace, apparel, automotive, avionics, chemicals, computer peripherals, communications, distribution, food and beverage, general manufacturing, packaging, and transportation. It has two segments, Product Identification (PI) and Test & Measurement (T&M). It generates the majority of its revenue from the PI segment that includes specialty printing systems and related supplies.
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.